AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home Mycology Article
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Article | Open Access

Evaluation of the hypoglycaemic and antioxidant effects of submerged Ganoderma lucidum cultures in type 2 diabetic rats

Chung-Hsiung HuangaWei-Kang LinaShun‐Hsien ChangbGuo-Jane Tsaia,c ( )
Department of Food Science, National Taiwan Ocean University, Keelung, Taiwan
Institute of Food Safety and Risk Management, National Taiwan Ocean University, Keelung, Taiwan
Center for Marine Bioscience and Biotechnology, National Taiwan Ocean University, Keelung, Taiwan
Show Author Information

Abstract

We aim to investigate the hypoglycaemic and antioxidant effects of submerged Ganoderma lucidum cultures and elucidate the potential mechanisms behind these effects using a type 2 diabetic rat model. Diabetic rats were daily fed with a high-fat diet supplemented with 1% or 3% freeze-dried whole submerged cultures of G. lucidum or mycelia for 5 weeks. We observed significantly decreased fasting plasma glucose levels, homoeostasis model assessment equation-insulin resistance, and plasma glucose in oral glucose tolerance test. Furthermore, we observed increased levels of glycogen, hepatic hexokinase, glucose-6-phosphate dehydrogenase, and intestinal disaccharidase activities. G. lucidum supplement downregulated the plasma levels of aspartate aminotransferase, alanine aminotransferase, creatinine, and urea nitrogen as well as liver and kidney levels of thiobarbituric acid reactive substances. Based on the hypoglycaemic and antioxidant effects of G. lucidum submerged cultures, we recommend the potential application of these products as functional foods or additives for controlling type 2 diabetes.

References

 

Bach EE, Hi EMB, Martins AMC, Nascimento PAM, Wadt NSY. 2018. Hypoglicemic and hypolipedimic effects of Ganoderma lucidum in streptozotocin-induced diabetic rats. Med (Basel). 5(3):78.

 

Boyko EJ, Magliano D, Shaw JE. 2007. Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the women’s health initiative observational study: response to Song et al. Diabetes Care. 30(11):e110. author reply e111.

 

Chang M-Y, Tsai G-J, Houng J-Y. 2006. Optimization of the medium composition for the submerged culture of Ganoderma lucidum by Taguchi array design and steepest ascent method. Enzyme Microb Technol. 38(3–4):407–414.

 

Dahlqvist A. 1968. Assay of intestinal disaccharidases. Anal Biochem. 22(1):99–107.

 

Erickson RH, Zakim D, Vessey DA. 1978. Preparation and properties of a phospholipid-free form of microsomal UDP-glucuronyltransferase. Biochem. 17(18):3706–3711.

 

Girometta C. 2019. Antimicrobial properties of fomitopsis officinalis in the light of its bioactive metabolites: a review. Mycol. 10(1):32–39.

 

Glinghammar B, Rafter I, Lindström AK, Hedberg JJ, Andersson HB, Lindblom P, Berg AL, Cotgreave I. 2009. Detection of the mitochondrial and catalytically active alanine aminotransferase in human tissues and plasma. Int J Mol Med. 23(5):621–623.

 

He CY, Li WD, Guo SX, Lin SQ, Lin ZB. 2006. Effect of polysaccharides from Ganoderma lucidum on streptozotocin-induced diabetic nephropathy in mice. J Asian Nat Prod Res. 8(8):705–711.

 

Heymann AD, Cohen Y, Chodick G. 2012. Glucose-6-phosphate dehydrogenase deficiency and type 2 diabetes. Diabetes Care. 35(8):e58.

 

Jia J, Zhang X, Hu Y-S, Wu Y, Wang Q-Z, Li -N-N, Guo Q-C, Dong X-C. 2009. Evaluation of in vivo antioxidant activities of Ganoderma lucidum polysaccharides in STZ-diabetic rats. Food Chem. 115(1):32–36.

 

Jiang X, Chang H, Zhou Y. 2015. Expression, purification and preliminary crystallographic studies of human glutamate oxaloacetate transaminase 1 (GOT1). Protein Expr Purif. 113:102–106.

 

Ma H-T, Hsieh J-F, Chen S-T. 2015. Anti-diabetic effects of Ganoderma lucidum. Phytochem. 114:109–113.

 

Manna P, Ghosh J, Das J, Sil PC. 2010. Streptozotocin induced activation of oxidative stress responsive splenic cell signaling pathways: protective role of arjunolic acid. Toxicol Appl Pharmacol. 244(2):114–129.

 

Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D, Novelli M, Ribes G. 1998. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes. 47(2):224–229.

 

Murat JC, Serfaty A. 1974. Simple enzymatic determination of polysaccharide (glycogen) content of animal tissues. Clin Chem. 20(12):1576–1577.

 

Neyrinck AM, Pachikian B, Taminiau B, Daube G, Frederick R, Cani PD, Bindels LB, Delzenne NM. 2016. Intestinal sucrase as a novel target contributing to the regulation of glycemia by prebiotics. PLoS One. 11(8):e0160488.

 

Ogbole OO, Nkumah AO, Linus AU, Falade MO. 2019. Molecular identification, in vivo and in vitro activities of Calvatia gigantea (macro-fungus) as an antidiabetic agent. Mycol. 10(3):166–173.

 

Olokoba AB, Obateru OA, Olokoba LB. 2012. Type 2 diabetes mellitus: a review of current trends. Oman Med J. 27(4):269–273.

 

Pan D, Zhang D, Wu J, Chen C, Xu Z, Yang H, Zhou P. 2013. Antidiabetic, antihyperlipidemic and antioxidant activities of a novel proteoglycan from ganoderma lucidum fruiting bodies on db/db mice and the possible mechanism. PLoS One. 8(7):e68332.

 

Raza H, Prabu SK, John A, Avadhani NG. 2011. Impaired mitochondrial respiratory functions and oxidative stress in streptozotocin-induced diabetic rats. Int J Mol Sci. 12(5):3133–3147.

 

Seto SW, Lam TY, Tam HL, Au AL, Chan SW, Wu JH, Yu PH, Leung GP, Ngai SM, Yeung JH, et al. 2009. Novel hypoglycemic effects of Ganoderma lucidum water-extract in obese/diabetic (+db/+db) mice. Phytomed. 16(5):426–436.

 

Shieh YH, Liu CF, Huang YK, Yang JY, Wu IL, Lin CH, Li SC. 2001. Evaluation of the hepatic and renal-protective effects of Ganoderma lucidum in mice. Am J Chin Med. 29(3–4):501–507.

 

Sloop KW, Showalter AD, Cox AL, Cao JX, Siesky AM, Zhang HY, Irizarry AR, Murray SF, Booten SL, Finger EA, et al. 2007. Specific reduction of hepatic glucose 6-phosphate transporter-1 ameliorates diabetes while avoiding complications of glycogen storage disease. J Biol Chem. 282(26):19113–19121.

 

Teng BS, Wang CD, Zhang D, Wu JS, Pan D, Pan LF, Yang HJ, Zhou P. 2012. Hypoglycemic effect and mechanism of a proteoglycan from ganoderma lucidum on streptozotocin-induced type 2 diabetic rats. Eur Rev Med Pharmacol Sci. 16(2):166–175.

 

Vitak TY, Wasser SP, Nevo E, Sybirna NO. 2015. The effect of the medicinal mushrooms Agaricus brasiliensis and Ganoderma lucidum (Higher basidiomycetes) on the erythron system in normal and streptozotocin-induced diabetic rats. Int J Med Mushrooms. 17(3):277–286.

 
Wachtel-Galor S, Yuen J, Buswell JA, Benzie IFF. 2011. Ganoderma lucidum (Lingzhi or Reishi): A medicinal mushroom. In: nd, Benzie IFF, Wachtel-Galor S, editors. Herbal medicine: biomolecular and clinical aspects. Boca Raton (FL): CRC Press/Taylor & Francis.
 

Wang CD, Teng BS, He YM, Wu JS, Pan D, Pan LF, Zhang D, Fan ZH, Yang HJ, Zhou P. 2012. Effect of a novel proteoglycan PTP1B inhibitor from Ganoderma lucidum on the amelioration of hyperglycaemia and dyslipidaemia in db/db mice. Br J Nutr. 108(11):2014–2025.

 

Wolosin JD, Edelman SV. 2000. Diabetes and the gastrointestinal tract. Clin Diabetes. 18(4):148.

 

Wu Y, Ding Y, Tanaka Y, Zhang W. 2014. Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci. 11(11):1185–1200.

 

Xiao C, Wu QP, Cai W, Tan JB, Yang XB, Zhang JM. 2012. Hypoglycemic effects of Ganoderma lucidum polysaccharides in type 2 diabetic mice. Arch Pharm Res. 35(10):1793–1801.

 

Zheng J, Yang B, Yu Y, Chen Q, Huang T, Li D. 2012. Ganoderma lucidum polysaccharides exert anti-hyperglycemic effect on streptozotocin-induced diabetic rats through affecting β-cells. Comb Chem High Throughput Screen. 15(7):542–550.

Mycology
Pages 82-93
Cite this article:
Huang C-H, Lin W-K, Chang S, et al. Evaluation of the hypoglycaemic and antioxidant effects of submerged Ganoderma lucidum cultures in type 2 diabetic rats. Mycology, 2021, 12(2): 82-93. https://doi.org/10.1080/21501203.2020.1733119

192

Views

14

Crossref

17

Web of Science

19

Scopus

Altmetrics

Received: 30 December 2019
Accepted: 01 February 2020
Published: 01 March 2020
© 2020 The Author(s).

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Return